David M. Goldenberg, SCD, MD | Authors

Commentary (Goldenberg): Diagnostic Use of Radiolabeled Antibodies for Cancer

July 01, 1995

The development of cancer imaging with radiolabeled antibodies, or radioimmunodetection (RAID), has spanned at least 2 decades, if we begin dating this from the use of antibodies made against human tumor-associated antigens, such as oncofetal